Raelene Leonard - Fisher Paykel Company Counsel
| FPH Stock | 34.57 0.54 1.59% |
Executive
Raelene Leonard is Company Counsel of Fisher Paykel Healthcare
| Address | 15 Maurice Paykel Place, Auckland, New Zealand, 2013 |
| Phone | 64 9 574 0100 |
| Web | https://www.fphcare.com |
Fisher Paykel Management Efficiency
The company has return on total asset (ROA) of 0.0985 % which means that it generated a profit of $0.0985 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0755 %, meaning that it generated $0.0755 on every $100 dollars invested by stockholders. Fisher Paykel's management efficiency ratios could be used to measure how well Fisher Paykel manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Fisher Paykel's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 2.4 B in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 79.8 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Thomas Fromm | Telix Pharmaceuticals | N/A | |
| Christian Davis | Telix Pharmaceuticals | N/A | |
| Tim Sharp | Talisman Mining | N/A | |
| Darren Patti | Telix Pharmaceuticals | 52 | |
| Claire Rosel | Ridley | N/A | |
| Kirsty Clarke | Ridley | N/A | |
| Nabil PGeo | Champion Iron | N/A | |
| Franois Lavoie | Champion Iron | N/A | |
| William Hundy | Champion Iron | N/A | |
| Meredith BDES | Telix Pharmaceuticals | N/A | |
| Craig Ulrick | Telix Pharmaceuticals | N/A | |
| Amanda Griffin | Telix Pharmaceuticals | N/A | |
| Kyahn BA | Telix Pharmaceuticals | N/A | |
| ACIS BSc | Talisman Mining | 49 | |
| Michael CFA | Champion Iron | N/A | |
| Ross Singh | Ridley | N/A | |
| Jeremy Cowan | Ridley | N/A | |
| Russell Gregory | Talisman Mining | N/A | |
| MBA MD | Telix Pharmaceuticals | 55 | |
| MBA CRIA | Champion Iron | N/A | |
| BSc BSc | Telix Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | 0.0755 | ||||
| Return On Asset | 0.0985 |
Fisher Paykel Healthcare Leadership Team
Elected by the shareholders, the Fisher Paykel's board of directors comprises two types of representatives: Fisher Paykel inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fisher. The board's role is to monitor Fisher Paykel's management team and ensure that shareholders' interests are well served. Fisher Paykel's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fisher Paykel's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hayden Brown, Head Relations | ||
| Justin Callahan, President Europe | ||
| Nicola Talbot, Vice Resources | ||
| Raelene Leonard, Company Counsel | ||
| Andrew Somervell, Vice Technology | ||
| Lyndal York, Chief Officer | ||
| Paul BCom, Senior Marketing | ||
| Marcus Driller, Vice Corporate | ||
| Karen Knott, Gen Communications | ||
| Daniel Adolph, Senior Manager | ||
| Lewis Gradon, CEO MD | ||
| Andy Niccol, COO Humidification | ||
| Sam Frame, Marketing Airvo | ||
| Jonathan Rhodes, Facilities Chain | ||
| Chris Crone, General Optiflow |
Fisher Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Fisher Paykel a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0755 | ||||
| Return On Asset | 0.0985 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 19.86 B | ||||
| Shares Outstanding | 583.98 M | ||||
| Shares Owned By Insiders | 8.17 % | ||||
| Shares Owned By Institutions | 39.56 % | ||||
| Price To Book | 12.60 X | ||||
| Price To Sales | 11.58 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fisher Stock Analysis
When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.